Related Experiment Video

Updated: Aug 11, 2026

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

8.8K

Exosomes Based Geldanamycin Delivery to Cancer Cells with Increased Therapeutic Efficacy

Akhila Dhayapulay, Mathumai Kanapathipillai

    Journal of Biomedical Nanotechnology
    |December 19, 2019
    PubMed

    Insights

    Exosomes effectively deliver the hydrophobic drug geldanamycin to cancer cells, enhancing its efficacy against Heat Shock Protein 90 (HSP90) and inhibiting tumor cell proliferation.

    Area of Science:

    • Oncology
    • Nanomedicine
    • Drug Delivery

    Background:

    • Heat Shock Protein 90 (HSP90) promotes cancer cell proliferation and oncogenic functions.
    • Geldanamycin is a potent HSP90 inhibitor, but its clinical use is limited by hydrophobicity and toxicity.
    • Targeted delivery is crucial to enhance geldanamycin's therapeutic efficacy.

    Purpose of the Study:

    • To investigate the potential of exosomes as a targeted delivery system for geldanamycin.
    • To evaluate the efficacy of exosome-loaded geldanamycin in inhibiting cancer cell proliferation.

    Main Methods:

    • Exosomes were isolated from cancer cells.
    • Exosomes were loaded with geldanamycin.
    • The therapeutic effects of exosome-delivered geldanamycin were assessed in cancer cells.

    Main Results:

    • Cancer cell-derived exosomes demonstrated specificity towards cancer cells.
    • Exosomes loaded with geldanamycin exhibited significantly increased efficacy compared to free geldanamycin.
    • Exosomal geldanamycin effectively inhibited cancer cell proliferation.

    Conclusions:

    • Exosomes represent a promising platform for delivering hydrophobic drugs like geldanamycin.
    • Exosomal formulations can overcome the limitations of free geldanamycin, improving its anti-cancer potential.
    • This strategy offers a novel approach for targeting HSP90 in cancer therapy.

    More Related Videos

    Preparation of Exosomes for siRNA Delivery to Cancer Cells09:59

    Preparation of Exosomes for siRNA Delivery to Cancer Cells

    Published on: December 5, 2018

    25.9K
    Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery09:09

    Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

    Published on: June 23, 2020

    6.4K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    Overview of Exosomes01:36

    Overview of Exosomes

    Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
    Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

    Site-Targeted Drug Delivery Systems: Polymeric Carriers

    Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...